8-K ·Filed Apr 10, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
This is a routine corporate governance adjustment with no operational or strategic implications. Traders should not expect stock movement based on this filing.
Final — all horizons settled through T+60d
SLDB ▲ +31.11% at T+60d
NEUTRAL call ✓ call won +31.11% · α vs SPY +22.19% · entry $8.39 → $11.00
T+1d
-1.91%
call -1.91% · α -3.12%
$8.23
settled 6mo ago
T+5d
+1.19%
call +1.19% · α -2.10%
$8.49
settled 6mo ago
T+20d
-8.46%
call -8.46% · α -16.19%
$7.68
settled 5mo ago
T+60d
+31.11%
call +31.11% · α +22.19%
$11.00
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Solid Biosciences Inc. announced a board seat reclassification for director Ilan Ganot, who resigned from Class III and was immediately reappointed to Class I to balance board composition. The move is procedural and does not reflect a change in leadership or strategy.
Key Facts
- Ilan Ganot resigned from Class III of the Board and was reappointed to Class I effective April 10, 2026
- The change was made to achieve equal balance among the three board classes
- No changes to Ganot's compensation or role responsibilities were made
- Stockholders will be asked to ratify the appointment on an advisory basis at the 2026 Annual Meeting
Financial Impact
No financial impact
compensationboard structure
Risk Factors
- Advisory ratification at the 2026 Annual Meeting could face shareholder opposition, though unlikely given the procedural nature
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-151259 |
| Document: 0001193125-26-151259-index-headers.html | 0001193125-26-151259 |
| Document: 0001193125-26-151259-index.html | 0001193125-26-151259 |
| Document: 0001193125-26-151259.txt | 0001193125-26-151259 |
11 reports for SLDB
100% Hit rate best @ T+20▲ +20.77%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 6, 2026 8w ago | S-3ASR | $8.39 $10.25 | ▲ +22.17% | ▲ +22.57% | $6.80 (−18.95%) |
May 12, 2026 20w ago | Press Release | $7.38 $7.22 | ▲ +2.17% | ▲ +1.56% | $6.80 (+7.86%) |
May 7, 2026 21w ago | Press Release | $7.07 $6.85 | ▼ −3.11% | ▼ −6.25% | $6.80 (−3.82%) |
Apr 23, 2026 23w ago | DEFA14A | $7.92 $6.50 | ▼ −17.93% | ▼ −21.96% | $6.80 (−14.14%) |
Apr 10, 2026 24w ago | 8-K | $8.39 $7.68 | ▼ −8.46% | ▼ −16.19% | $6.80 (−18.95%) |
Apr 1, 2026 26w ago | EFFECT | $7.38 $7.05 | ▲ +4.47% | ▲ +14.19% | $6.80 (+7.86%) |
Mar 19, 2026 28w ago | Press Release | $7.03 $8.49 | ▲ +20.77% | ▲ +11.45% | $6.80 (−3.27%) |
Mar 12, 2026 29w ago | 8-K | $7.71 $8.02 | ▲ +4.02% | ▲ +2.05% | $6.80 (−11.80%) |
Mar 11, 2026 29w ago | Press Release | $7.72 $8.10 | ▲ +4.99% | ▲ +4.47% | $6.80 (−11.86%) |
Mar 6, 2026 30w ago | Press Release | $6.75 $7.74 | ▲ +14.67% | ▲ +16.71% | $6.80 (+0.74%) |
Showing 10 of 11
US Market Status
Market Open — Closes in 40m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access